Squamous cell carcinoma of the conjunctiva invading the orbit in a non-Hodgkin lymphoma.
Kwon
Soon-Il
SI
Department of Ophthalmology, Hallym University Sacred Heart Hospital, Anyang, Korea.
Chung
Yun Suk
YS
Department of Ophthalmology, Hallym University Sacred Heart Hospital, Anyang, Korea.
Kim
Yun-Jeong
YJ
Department of Ophthalmology, Hallym University Sacred Heart Hospital, Anyang, Korea. bonamd@paran.com.|Department of Ophthalmology, Hallym University Sacred Heart Hospital, #896 Pyungchon-dong, Anyang, Gyeonggi-do, 431-070, Korea. bonamd@paran.com.
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D003230:Conjunctival Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D009361:Neoplasm Invasiveness; D016609:Neoplasms, Second Primary / Q000473:pathology*; D017233:Orbit Evisceration; D009918:Orbital Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D011241:Prednisone / Q000627:therapeutic use; D012074:Remission Induction; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone